Why is Morepen Labs. falling/rising?

As of 19-Aug, Morepen Laboratories Ltd is experiencing a price increase, with its current price at 48.85, reflecting a rise of 0.75 or 1.56%. The stock has outperformed its sector today by 1.69% and has shown a consecutive gain over the last two days, accumulating a total return of 5.26% during this period. However, despite this recent uptick, the stock's performance over the past month has been significantly negative, with a decline of 21.93%. The company has a low Debt to Equity ratio and an attractive valuation with a Price to Book Value of 2.3, but it has faced challenges, including a 21.3% drop in profits over the past year and negative results in the last two quarters, which may contribute to investor caution.
In the broader market context, Morepen Laboratories Ltd's short-term return of 4.63% over the past week outpaces the Sensex's return of 1.76%, indicating a relatively stronger performance compared to the benchmark. However, the stock's year-to-date performance is concerning, with a decline of 37.61% compared to the Sensex's gain of 4.49%. This underperformance in the long term, alongside a lack of domestic mutual fund investment, suggests that investor confidence may be wavering, despite the recent price increase. Overall, while the stock has shown some positive movement recently, the underlying financial challenges and broader market trends indicate a complex situation for Morepen Laboratories Ltd.